• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定片剂中阿托伐他汀及监测其在固相中稳定性的高效液相色谱法的验证

Validation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phase.

作者信息

Stanisz Beata, Kania Lukasz

机构信息

Department of Pharmaceutical Chemistry, Poznań University of Medical Sciences, Poznań, Poland.

出版信息

Acta Pol Pharm. 2006 Nov-Dec;63(6):471-6.

PMID:17438862
Abstract

A rapid high performance liquid chromatographic method was developed and validated for determination of atorvastatin in pharmaceutical dosage forms, and for evaluation of its stability in the solid phase. Separation of atorvastatin was successfully achieved on a C-18 column utilizing water--acetonitrile at the volumetric ratio of 48:52, adjusted to pH 2.0 with 80% ortho-phosphoric acid. The detection wavelength was 245 nm. The method was validated and the response was found to be linear in the drug concentration range of 0.04 mg/mL - 0.4 mg/mL. The mean values +/- RSD of the slope and the correlation coefficient were 8.192 +/- 0.260 and 0.999, respectively. The RSD values for intra- and interday precision were < 1.00% and 0.90%, respectively. The degradation kinetic of atorvastatin at 363 K in a relative humidity of 76.4% was observed to be autocatalytic first order reaction. The kinetic parameters were as follows: k (where k represents the velocity constant; s(-1)) = (1.42 +/- 0.19) 10(-6); t(0.5) (where t(0.5) represents the time needed for a 50% decay of atorvastatin; days) = 32.82 +/- 0.9; t(0.1) (where t(0.1) represents the time needed for a 10% decay of atorvastatin; days) = 13.86 +/- 0.8.

摘要

建立并验证了一种快速高效液相色谱法,用于测定药物剂型中的阿托伐他汀,并评估其在固相中稳定性。在C-18柱上,以体积比48:52的水 - 乙腈为流动相,用80%的正磷酸调节pH至2.0,成功实现了阿托伐他汀的分离。检测波长为245 nm。该方法经过验证,在0.04 mg/mL - 0.4 mg/mL的药物浓度范围内响应呈线性。斜率和相关系数的平均值±相对标准偏差分别为8.192±0.260和0.999。日内和日间精密度的相对标准偏差值分别<1.00%和0.90%。观察到阿托伐他汀在363 K、相对湿度76.4%条件下的降解动力学为自催化一级反应。动力学参数如下:k(其中k表示速度常数;s(-1))=(1.42±0.19)×10(-6);t(0.5)(其中t(0.5)表示阿托伐他汀降解50%所需时间;天)=32.82±0.9;t(0.1)(其中t(0.1)表示阿托伐他汀降解10%所需时间;天)=13.86±0.8。

相似文献

1
Validation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phase.用于测定片剂中阿托伐他汀及监测其在固相中稳定性的高效液相色谱法的验证
Acta Pol Pharm. 2006 Nov-Dec;63(6):471-6.
2
Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets.用于同时测定片剂中阿托伐他汀、非诺贝特及其降解产物的稳定性指示超高效液相色谱法
J Pharm Biomed Anal. 2008 Sep 10;48(1):120-6. doi: 10.1016/j.jpba.2008.05.018. Epub 2008 May 21.
3
A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.一种用于同时测定市售片剂中阿托伐他汀和氨氯地平的稳定性指示高效液相色谱(HPLC)分析方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846(1-2):215-21. doi: 10.1016/j.jchromb.2006.09.007. Epub 2006 Sep 28.
4
Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe.采用超高效液相色谱法开发并验证阿托伐他汀和依折麦布固定剂量复方制剂的稳定性指示测定方法。
J Chromatogr Sci. 2013 Mar;51(3):222-8. doi: 10.1093/chromsci/bms131. Epub 2012 Aug 3.
5
Isolation and structure determination of oxidative degradation products of atorvastatin.阿托伐他汀氧化降解产物的分离与结构鉴定。
J Pharm Biomed Anal. 2009 Dec 5;50(5):729-36. doi: 10.1016/j.jpba.2009.06.008. Epub 2009 Jun 12.
6
Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detection: method development, validation and optimization of various experimental parameters.采用反相高效液相色谱/紫外检测法同时测定人血清中罗苏伐他汀和阿托伐他汀:方法开发、验证及各种实验参数的优化。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Mar 15;879(9-10):557-63. doi: 10.1016/j.jchromb.2011.01.004. Epub 2011 Jan 12.
7
An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets.一种用于测定原料药和片剂中阿托伐他汀及其杂质的高效液相色谱法。
J Pharm Biomed Anal. 2003 Dec 4;33(5):1017-23. doi: 10.1016/s0731-7085(03)00408-4.
8
Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection.采用反相高效液相色谱-紫外检测法测定人血清中的阿托伐他汀。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Nov 5;826(1-2):41-5. doi: 10.1016/j.jchromb.2005.08.008. Epub 2005 Sep 16.
9
Simultaneous determination of amlodipine and atorvastatin with its metabolites; ortho and para hydroxy atorvastatin; in human plasma by LC-MS/MS.采用 LC-MS/MS 法同时测定人血浆中的氨氯地平和阿托伐他汀及其代谢物(对羟基阿托伐他汀和邻羟基阿托伐他汀)。
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Feb 15;917-918:36-47. doi: 10.1016/j.jchromb.2013.01.001. Epub 2013 Jan 9.
10
Isocratic RP-HPLC method for rutin determination in solid oral dosage forms.用于测定固体口服剂型中芦丁的等度反相高效液相色谱法。
J Pharm Biomed Anal. 2007 Jan 17;43(2):718-21. doi: 10.1016/j.jpba.2006.07.019. Epub 2006 Aug 22.

引用本文的文献

1
Design and Characterization of Atorvastatin Dry Powder Formulation as a potential Lung Cancer Treatment.阿托伐他汀干粉制剂作为潜在肺癌治疗药物的设计与表征
Saudi Pharm J. 2021 Dec;29(12):1449-1457. doi: 10.1016/j.jsps.2021.11.002. Epub 2021 Nov 11.
2
Two spectrophotometric methods for simultaneous determination of some antihyperlipidemic drugs.两种同时测定某些降血脂药物的分光光度法。
J Pharm Anal. 2012 Aug;2(4):279-284. doi: 10.1016/j.jpha.2012.02.002. Epub 2012 Feb 21.
3
Effect of and gene polymorphisms on atorvastatin metabolism in a Mexican population.
和基因多态性对墨西哥人群中阿托伐他汀代谢的影响。
Biomed Rep. 2017 Dec;7(6):579-584. doi: 10.3892/br.2017.1009. Epub 2017 Oct 25.
4
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.一项药物遗传学初步研究表明,MTHFR、DRD3和MDR1基因多态性可作为阿托伐他汀代谢缓慢者的生物标志物候选指标。
BMC Cancer. 2016 Feb 8;16:74. doi: 10.1186/s12885-016-2062-2.
5
Optimized zein nanospheres for improved oral bioavailability of atorvastatin.用于提高阿托伐他汀口服生物利用度的优化玉米醇溶蛋白纳米球。
Int J Nanomedicine. 2015 Jun 19;10:4059-69. doi: 10.2147/IJN.S83906. eCollection 2015.
6
Validated spectrophotometric methods for the simultaneous determination of telmisartan and atorvastatin in bulk and tablets.验证的分光光度法同时测定原料药和片剂中的替米沙坦和阿托伐他汀。
Pharm Methods. 2012 Jul;3(2):112-6. doi: 10.4103/2229-4708.103892.
7
An improved HPLC method with the aid of a chemometric protocol: simultaneous determination of atorvastatin and its metabolites in plasma.一种改进的 HPLC 方法,辅以化学计量学方案:同时测定血浆中的阿托伐他汀及其代谢物。
Molecules. 2013 Feb 25;18(3):2469-82. doi: 10.3390/molecules18032469.
8
A validated densitometric method for analysis of atorvastatin calcium and metoprolol tartarate as bulk drugs and in combined capsule dosage forms.一种经过验证的密度测定法,用于分析阿托伐他汀钙和酒石酸美托洛尔原料药及复方胶囊剂型。
J Young Pharm. 2011 Jan;3(1):55-9. doi: 10.4103/0975-1483.76420.